Nolan Williams, MD

  • 2Articles
  • 14.1KReads
  • 2023–2024Active
  • 7Collaborators
  • 14Citations

About

Nolan Williams, MD, has published research focused on major depressive disorder, specifically exploring neuromodulation therapies such as Stanford Accelerated Intelligent Neuromodulation Therapy and repetitive transcranial magnetic stimulation for treatment-resistant depression. Williams's work addresses clinical applications and policy issues related to these interventions. The author has collaborated with colleagues including Conor Liston, Cory R. Weissman, Daniel M. Blumberger, Jeffrey Voigt, and Paul B. Fitzgerald.

Publications

JCP
Algorithms for TRD Treatment Success
Insights

Algorithms for TRD Treatment Success

September 27, 2024

Dr. Nolan Williams delves into the innovative Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for treating resistant depression. Explore groundbreaking research, clinical trials, and the transformative potential of personalized brain...
JCP
rTMS for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies
Commentary

rTMS for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies

April 26, 2023

The authors argue that insurance companies’ prior authorization process overly restricts access to rTMS, which has proven effectiveness for TRD.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe